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Abstract
Leishmania donovani is a protozoan parasite that causes visceral leishmaniasis (VL) and is responsible for significant
mortality and morbidity. Increasing resistance towards antimonial drugs poses a great challenge in chemotherapy of VL.
Paromomycin is an aminoglycosidic antibiotic and is one of the drugs currently being used in the chemotherapy of
cutaneous and visceral leishmaniasis. To understand the mode of action of this antibiotic at the molecular level, we have
investigated the global proteome differences between the wild type AG83 strain and a paromomycin resistant (PRr) strain of
L. donovani. Stable isotope labeling of amino acids in cell culture (SILAC) followed by quantitative mass spectrometry of the
wild type AG83 strain and the paromomycin resistant (PRr) strain identified a total of 226 proteins at$95% confidence. Data
analysis revealed upregulation of 29 proteins and down-regulation of 21 proteins in the PRr strain. Comparative proteomic
analysis of the wild type and the paromomycin resistant strains showed upregulation of the ribosomal proteins in the
resistant strain indicating role in translation. Elevated levels of glycolytic enzymes and stress proteins were also observed in
the PRr strain. Most importantly, we observed upregulation of proteins that may have a role in intracellular survival and
vesicular trafficking in the PRr strain. Furthermore, ultra-structural analysis by electron microscopy demonstrated increased
number of vesicular vacuoles in PRr strain when compared to the wild-type strain. Drug affinity pull-down assay followed by
mass spectrometery identified proteins in L. donovani wild type strain that were specifically and covalently bound to
paromomycin. These results provide the first comprehensive insight into the mode of action and underlying mechanism of
resistance to paromomycin in Leishmania donovani.
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Introduction
Paromomycin is an aminoglycosidic antibiotic which was initially
used against bacterial infection [1]. It is also used against giardiasis,
amoebaiasis [2] and cryptosporidiosis [3]. The mechanism of action
of paromomycin has been well studied in E. coli. It is known to
inhibit protein synthesis by interacting with the ribosomal subunits
[1]. It has also been shown to inhibit the anti-association activity of
initiation factor 3 and promote association of the ribosomal subunits
[4]. It is known to bind to the major groove in the A-site of 16S
rRNA in E. coli and induces misreading of mRNA [5].
The protozoan parasite Leishmania is the causative agent of kala-
azar and is responsible for a variety of clinical manifestations.
Visceral leishmaniasis (VL) is caused by L. donovani in the Indian
sub-continent. Pentavalent antimonials (SbV) are the first line of
drug used in the treatment against all forms of leishmanial
infections [6,7]. Resistance to this drug has become a major
barrier in the treatment of VL in many endemic regions
particularly in India [8]. A parenteral formulation of aminosidine
(paromomycin) has been approved for leishmaniasis treat-
ment in India [9–11], where it is in phase IV trials (http://www.
oneworldhealth.org/press_releases/release/pr_1227120528). It has
proved to be useful against cutaneous (as both topical and parenteral
formulation) and visceral leishmaniasis (as parenteral formulation)
[12,13].
The mode of action of paromomycin is not clear in case of
Leishmania. It has been proposed that it might alter membrane
fluidity, interact with ribosomes, interfere with the mitochondrial
membrane potential and inhibit respiration [14]. We had earlier
elucidated the effect and mechanism of uptake of paromomycin in
Leishmania donovani [15]. A line selected for resistance to the drug
showed reduced paromomycin accumulation associated with a
significant reduction in the initial binding to the cell surface. The
drug induced reduction in membrane potential and inhibition of
protein synthesis were less pronounced in the resistant strain in
comparison to the wild-type [15]. Recent report indicates
differential effects of paromomycin on the translation processes
of the Leishmania parasite and its mammalian hosts [16].
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Drug resistance is a multifactorial problem due to changes in the
expression levels and activity of a wide number of proteins.
Quantification of mRNA levels between drug resistant and drug
sensitive cell lines unfortunately do not always correlate with
protein expression levels due to post-transcriptional changes in
protein abundance. Therefore global quantitative proteomics
screens are needed to identify the protein targets that are
differentially expressed in drug resistant cell lines. Protein profiling
has previously been applied to understand the stage- specific gene
expression, drug resistance mechanism, identification of virulence
factors and characterization of immunodominant antigens [17–
20]. Earlier reports on comparative protein profiling of the wild
type and the antimonial-resistant strain showed that the heat shock
protein and kinetoplastid calpain related proteins modulate
susceptibility to antimonials [21]. In another study novel roles
were revealed for methionine adenosyl transferase in methotrexate
resistance in Leishmania [18].
In order to understand the mode of action and possible
mechanism of resistance of this antibiotic at the molecular level,
we have investigated the protein expression profile of genetically
related pair of paromomycin susceptible/-resistant strains. A
quantitative proteomic approach based on stable isotope labeling
of amino acids in cell culture (SILAC) followed by high resolution
mass spectrometry was employed to analyze the differences in the
proteome of the wild type and the PRr resistant strain.
Paromomycin- resistant promastigotes were generated previously
under step-wise exposure to paromomycin and were found to
display a three-fold increase in resistance compared to the wild-
type [15]. Drug affinity pull-down assay followed by mass
spectrometery revealed a number of proteins in L. donovani which
might be interacting with paromomycin. Internalization probably
then appears to proceed by endocytosis as reported in our earlier
studies [15]. Upregulation of proteins involved in vesicular
trafficking in the PRr strain further supports sequestration of drug
in the vesicular cytoplasmic compartment. Ultrastructural studies
demonstrated increased number of vesicular vacuoles in the PRr
strain when compared to the wild-type strain. Up-regulation of
proteins involved in the translational machinery especially the
ribosomal proteins in the PRr strain indicates that once into the
cell PR inhibits protein synthesis by targeting the ribosomal
proteins. The identified parasite proteins provide an insight in to
the mode of action and underlying mechanism of resistance to
paromomycin in Leishmania. Furthermore, it allowed us to
reinterpret and extend earlier findings, identifying additional
processes hitherto only suspected to be involved in its mode of
action and underlying mechanism of resistance in L. donovani.
Results
Identification of Proteins Differentially Expressed in Wild
Type (WT) and the Paromomycin Resistant (PRr) Strain
We have compared the proteome of the wild type (WT) strain,
AG83-S with the PRr strain. Comparative proteomic studies using
SILAC technology was employed to reveal proteins that are
involved in mediating drug resistance. Briefly, the WT and the
PRr strains were cultured in the medium supplemented with
normal amino acids [L-lysine (70 mg/L) and L-arginine (70 mg/
L)] and isotopically labeled 13C6 L-lysine-HCl and
13C6
15N4 L-
arginine-HCl respectively. A schematic diagram illustrating the
experimental outline is shown in Figure 1. Equal amount of
protein (100 mg) from the sensitive and the resistant strains were
mixed and subjected to the first dimension chromatography and
the peptide masses obtained from mass-spectrometry analysis were
characterized using the L. infantum V3 proteome version 3.0 (ftp://
ftp.sanger.ac.uk/pub/pathogens/L_infantum/). Supplementary
Table S1 in the supporting information includes all the protein
IDs with$95% confidence from two individual datasets with their
respective ratios and p-values. A total of 226 distinct proteins were
identified out of which 197 proteins had a known or predicted
function and 29 proteins had no known function (hypothetical
proteins). Supplementary Table S2 includes merged datasets and
functional annotation of all the non-redundant proteins identified
at$95% confidence and$2 peptides. According to the functional
description, all significantly identified proteins fell into 7 major
groups: cell cytoskeleton, metabolic enzymes, chaperones/stress
proteins, translation, proteins involved in intracellular survival,
Figure 1. Experimental outline of the SILAC experiment. Paromomycin resistant cells (PRr) and AG83 wild type (WT) were grown on
isotopically heavy and light media respectively. The cells from both the strains were lysed and light and heavy cell lysates were combined. Protein
samples were reduced, alkylated and digested with trypsin into peptide samples that were then analyzed by LC-MS/MS. Quantification of SILAC
peptide pairs was performed with the SEQUEST algorithm against L. infantum protein database ver 3.0 (ftp://ftp.sanger.ac.uk/pub/pathogens/
L_infantum/). The SEQUEST output files were analyzed and validated by PeptideProphet.
doi:10.1371/journal.pone.0026660.g001
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RNA and DNA processing, signal transduction and hypothetical
proteins. The relative distribution of proteins is shown in Figure 2.
The up- and down- regulated hits are combined in each group.
Among the strictly quantitated proteins, we defined the
following thresholds for selecting proteins that had significantly
altered expression: 1) proteins identified by the software having
$95% confidence; 2) the ratio is either $1.5 or #0.5 and 3)
proteins having $2 peptides. Applying these filtering criteria,
subsets of regulated proteins were identified and then the total
number of protein IDs and the number of regulated hits (meeting
all three requirements) found in the experiment was determined as
detailed in the methods section. The proteins which were $1.5
fold were considered to be upregulated whereas the proteins which
were #0.5 fold were considered to be down regulated. Using these
stringent parameters, 29 proteins were found to be up-regulated
and 21 proteins were found to be down-regulated and rest of the
proteins remained unchanged in the PRr strain in comparison to
the wild type (Table 1 and Table 2). Figure 3 shows the percentage
of up- and down regulated proteins based on their functional
classification.
Increased Glycolysis and Energy producing Metabolic
Pathways in the Paromomycin Resistant strain (PRr)
Leishmania mainly uses glycolytic and pentose phosphate pathway
enzymes for energy generation. Several enriched biological
pathways from the subset of proteins identified with increased
expression in the paromomycin resistant L. donovani are related to
glycolysis. The enzymes of the glycolytic pathway were found to be
significantly upregulated in the PRr strain except for the enzyme
phoshoglycerate kinase which was found to be downregulated (,10
fold) in the PR resistant strain. Other proteins, such as NADH
dependent fumarate reductase putative and NADH dependent
fumarate reductase like protein were also found to be downregu-
lated (,4 and ,2 fold respectively) in the paromomycin resistant
cells. This enzyme is involved in the conversion of fumarate to
succinate and enables the organism to switch to anaerobic
respiration. The protein 6-phosphogluconate dehydrogenase, the
first committed enzyme of the pentose phosphate pathway was also
found to be down regulated (,2.7 fold) in the paromomycin
resistant parasites. This indicates that the PRr strain heavily relies
on glycolysis for its energy requirements. Increased glycolytic
activity under normal aerobic conditions is probably associated with
mitochondrial dysfunction. A high glycolysis rate also helps reduce
oxidative stress because the product of anaerobic glycolysis,
pyruvate, is a scavenger of hyperoxide.
Additional enriched metabolic pathways with enzymes display-
ing altered expression levels include the TCA cycle and lipid
metabolism. Proteins involved in oxidative phosphorylation,
ATPase alpha subunit and cytochrome c oxidase subunit IV were
found to be downregulated in the PRr strain. Acyl carrier protein,
which is a part of Type II fatty acid synthesis pathway, was found
to be upregulated (,1.8-fold) in the PRr strain. This pathway is
used for lipoic acid biosynthesis which is an essential co-factor for
the mitochondrial enzymes pyruvate dehydrogenases and 2-keto
glutarate dehydrogenase present in the TCA cycle [22]. Another
enzyme, S-adenosyl methionine synthetase was found to be ,1.6
upregulated in the PRr strain. S-adenosyl methionine dependent
RNA methylase, which methylates 16S rRNA in E. coli has been
associated with resistance to kasugamycin, an inhibitor of protein
synthesis [23].
Modulation of Proteins Involved in Intracellular Survival,
Processing and Virulence
The vesicular sequestration of drugs is a well known mechanism
of drug resistance in some mammalian cell lines which results in
lower cytoplasmic drug levels by sequestration of drugs in to a
vesicular cytoplasmic compartment [24–26]. Drug resistance by
sequestration in the vesicles has also been proposed for the
antimony resistant Leishmania parasites. In Leishmania, trivalent
antimony conjugates to trypanothione and is sequestered inside a
vacuole by ABC (ATP binding cassette) transporter, P glycopro-
tein A (PGPA) [27]. We observed upregulation of both vesicle-
fusing ATPase (,2.8 fold) and vacuolar ATP synthase subunit B
(,1.6 fold) in the PRr strain.
Transmission electron microscopy was employed in order to
document the differences between the wild type and the PRr
Figure 2. Pie diagram showing distribution of Leishmania proteins identified by quantitative proteomics technique using stable
isotope labeling with amino acids in cell culture (SILAC) coupled with mass spectrometry to quantify changes in protein levels
between paromomycin resistant (PRr) and sensitive cells. Proteins were grouped according to their cellular functions. The up- and down-
regulated hits are combined in each group.
doi:10.1371/journal.pone.0026660.g002
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Table 1. Proteins upregulated in the paromomycin resistant (PRr) strain.
S. No. Accession No.
Name of the Protein
(Up-regulated) PRr:WT ratio P-value
Percent
Coverage
Total Number
of Peptides
Translation
1 LinJ15_V3.1530 Ribosomal protein S6, putative 1.5760.4 4.21E-01 34.9 6
2 LinJ28_V3.0570LinJ30_V3.3240 Ribosomal protein s26, putative 3.4760.6 2.05E-02 15.2 2
3
LinJ28_V3.1050
LinJ30_V3.3650
40S ribosomal protein S14 1.6561 5.39E-01 29.2 14
4
LinJ32_V3.0930
LinJ35_V3.0600
60S ribosomal protein L18a, putative 1.5660.3 4.07E-01 6.7 3
5 LinJ36_V3.0210 Elongation factor 2 1.5 58.8 5
Metabolic Enzymes
Glycolysis
6 LinJ14_V3.1240 Enolase 2.4 67.8 9
7
LinJ21_V3.0300
LinJ21_V3.0310
Hexokinase, putative 1.561.1 6.52E-01 10.6 8
8 LinJ24_V3.0870 Triosephosphate isomerase 1.5160.5 5.06E-01 10.8 9
9
LinJ30_V3.2990
LinJ30_V3.3000
Glyceraldehyde 3-phosphate
dehydrogenase, glycosomal
1.9460.6 2.68E-01 30.2 138
10 LinJ36_V3.6960
2,3-bisphosphoglycerate-independent
phosphoglycerate mutase
1.5760.6 4.85E-01 5.6 2
Other Metabolic Enzymes
11 LinJ16_V30560
Orotidine-5-phosphate decarboxylase/
orotate phosphoribosyltransferase, putative
1.5660.5 4.66E-01 12 21
12 LinJ24_V3.0780 Malic enzyme 1.7861.5 5.52E-01 4.6 3
13 LinJ27_V3.0300 Acyl carrier protein, putative 1.7860.2 2.67E-01 12 4
14
LinJ30_V3.3560
LinJ30_V3.3580
S-adenosylmethionine synthetase 1.6360.07 3.38E-01 2.3 2
Chaperones/Stress Proteins
15 LinJ26_V3.1220 Heat shock protein 70-related protein 2.1160.2 1.50E-01 15.8 7
16 LinJ28_V3.3060 Heat-shock protein hsp70, putative 2.5467 62.5 10
17 LinJ30_V3.2480
Heat shock 70-related protein 1,
mitochondrial precursor, putative
2.01 49.7 3
18 LinJ32_V3.3470 Chaperonin alpha subunit, putative 5.7560.4 6.65E-04 7.9 5
19 LinJ36_V3.7240 Chaperonin, putative 2.2660.2 1.16E-01 7.8 6
DNA/RNA Processing
20 LinJ35_V3.2240 RNA-binding protein, putative 1.560.7 5.71E-01 12.4 8
21 LinJ36_V3.3960 Basic transcription factor 3a, putative 2.6860.9 1.07E-01 35 17
Proteins Involved in Intracellular Survival/Processing
22 LinJ11_V3.0350 14-3-3 protein, putative 1.6460.6 4.41E-01 13.4 7
23 LinJ12_V3.0730
NADH:flavin oxidoreductase/NADH
oxidase, putative
2.8962.7 3.13E-01 9 5
24 LinJ19_V3.0150 Aminopeptidase, putative 1.7360.2 2.93E-01 11.1 6
25 LinJ20_V3.0820 Vesicle-fusing ATPase, putative 2.860.4 5.21E-02 6.1 3
26
LinJ24_V3.1560
LinJ24_V3.1570
IgE-dependent histamine-releasing factor,
putative
1.7560.2 2.88E-01 5.3 2
27 LinJ28_V3.2610 Vacuolar ATP synthase subunit B, putative 1.6461.2 5.75E-01 4.8 2
28 LinJ29_V3.0790
Lipophosphoglycan biosynthetic protein,
putative
2.0160.2 1.77E-01 5.6 3
29 LinJ36_V3.3360 14-3-3 protein-like protein 1.5660.5 4.59E-01 22.9 10
List of proteins with increased expression levels in the PR resistant strain.
Fold change of protein level measured by SILAC with standard deviation is given as PRr:WT ratio.
p-value determined here were analyzed and validated by PeptideProphet.
doi:10.1371/journal.pone.0026660.t001
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strain. The ultra-structural analysis of the paromomycin resistant
strain revealed a greater number of vesicular vacuoles when
compared to the sensitive wild type strain (Figure 4A and B). It is
possible that vesicular sequestration of paromomycin into vacuoles
by these resistant parasites might be involved in conferring the
resistance phenotype.
We also observed increased expression of proteins that are
involved in intracellular survival and virulence including lipopho-
sphoglycan biosynthetic protein (LPG) putative, aminopeptidase
IgE-dependent histamine releasing factor and NADH oxidase
putative. Another protein, prohibitin, showed decreased protein
expression levels (,2.5 fold) in the PRr resistant strain. Prohibitin
has been reported to play an important role in the events leading
to Leishmania-host interaction [28]. Its homolog has been studied in
Trypanosoma brucei and has been reported to be upregulated upon
induction of apoptosis [29]. Down regulation of prohibitin in the
present study possibly indicates that the PR resistant cells are able
to survive by suppressing the expression of pro-apoptotic proteins.
Two proteins, annotated as ‘‘14-3-3 protein like protein’’ and ‘‘14-
3-3 protein putative’’ were found to be upregulated in the PRr
strain. These proteins are capable of binding to numerous
phosphorylated proteins including transcription factors, biosyn-
Table 2. Proteins downregulated in the paromomycin resistant (PRr) strain.
S. No. Accession No.
Name of the Protein
(Down-regulated) PRr:WT ratio P-value
Percent
coverage
Total Number
of Peptides
Translation
1 LinJ11_V3.1160 Eukaryotic release factor 3, putative 0.17 1.45E-03 5.3 3
2 LinJ18_V3.0630
LinJ36_V3.3950
60S ribosomal protein L10a, putative 0.2460.2 1.99E-01 22 5
3 LinJ22_V3.1370
LinJ22_V3.1410
40S ribosomal protein L14, putative 0.2360.1 8.20E-03 5.2 4
4 LinJ30_V3.0470 Aspartyl-tRNA synthetase, putative 0.0960.01 8.88E-06 3.6 3
5 LinJ35_V3.2040 60S ribosomal protein L32 0.2760.2 1.88E-01 31.6 5
Cell cytoskeleton
6 LinJ14_V3.1190 Kinesin K39, putative 0.360.04 2.40E-02 7.3 2
Metabolic Enzymes
Glycolysis
7 LinJ20_V3.0110
LinJ20_V3.0120
Phosphoglycerate kinase C, glycosomal 0.160.1 6.67E-02 19.1 14
Krebs cycle
8 LinJ35_V3.0850 NADH-dependent fumarate reductase-like protein 0.4760.07 1.62E-01 2.3 3
9 LinJ35_V3.1190 NADH-dependent fumarate reductase, putative 0.2460.02 5.57E-03 8.5 6
Electron Transport Chain
10 LinJ05_V3.0500
LinJ05_V3.0510
ATPase alpha subunit 0.4560.27 3.12E-01 18.8 16
11 LinJ12_V3.0620 Cytochrome c oxidase subunit iv 0.2560.28 2.61E-01 7.4 2
Other Metabolic Enzymes
12 LinJ31_V3.2320 3,2-trans-enoyl-CoA isomerase, mitochondrial
precursor, putative
0.3960.03 6.69E-02 8.8 2
13 LinJ35_V3.3390 6-phosphogluconate dehydrogenase,
decarboxylating putative
0.3660.03 4.79E-02 8.6 3
Chaperones/Stress Proteins
14 LinJ21_V3.1330 t-complex protein 1, delta subunit, putative 0.4760.03 1.40E-01 12 4
15 LinJ35_V3.3900 t-complex protein 1, eta subunit, putative 0.4260.1 1.09E-01 15.6 6
DNA/RNA Processing
16 LinJ15_V3.1500 Proliferative cell nuclear antigen (PCNA), putative 0.2760.1 2.87E-02 11.6 3
17 LinJ19_V3.0090 Fibrillarin, putative 0.4560.1 1.69E-01 12.2 2
18 LinJ32_V3.0410 ATP-dependent RNA helicase, putative 0.2760.2 1.58E-01 11.9 6
Proteins Involved in Intracellular Survival/Processing
19 LinJ35_V3.0070 Prohibitin, putative 0.460.03 7.79E-02 7.9 2
Hypothetical Proteins
20 LinJ10_V3.0910 Hypothetical protein, conserved 0.4760.1 1.48E-01 12.8 2
21 LinJ35_V3.0140 Hypothetical protein, conserved 0.2260.2 1.61E-01 21.8 3
List of proteins with decreased expression levels in the PR resistant strain.
Fold change of protein level measured by SILAC with standard deviation is given as PRr:WT ratio.
p-value reported here were analyzed and validated by PeptideProphet.
doi:10.1371/journal.pone.0026660.t002
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thetic enzymes, cytoskeletal proteins, signaling molecules and
display important anti-apoptotic characteristics [30].
Chaperones and Stress Proteins
A number of chaperones and stress proteins showed increased
expression levels in the PRr strain. Analysis of the data revealed
upregulation in the levels in the PRr strain; namely three HSPs
(.2 fold) and two chaperonins (.2 fold). All the three HSPs
belong to the HSP70 family. Heat shock proteins have been shown
to confer resistance against drugs [31].
Proteins involved in Translation Machinery
Paromomycin is known to bind to the small subunit of
ribosomes and inhibit protein synthesis [1]. Our data analysis
revealed that three out of four significantly upregulated
proteins are components of small ribosomal subunit. A total
of 56 proteins involved in translation including ribosomal
subunit proteins and translation factors were identified by
SILAC. Upregulation of ribosomal proteins rpS26 (,3.5 fold)
and rpS6 (,1.57 fold) was detected in the paromomycin
resistant strain. These two proteins have also been found to be
involved in self-translation regulation in humans. Ribosomal
protein, rpS26 has been shown to be important for the normal
growth of S. cerevisiae [32]. Ribosomal protein, rpL18a putative
has been implicated in cell growth regulation and was seen to
be upregulated (,1.5 fold). Translational factor, EF3 was found
to be downregulated in the paromomycin resistant strain
(,5.88 fold).
Figure 3. Bar diagram showing the proteins that were up/downregulated in PR resistant strain. The proteins have been grouped
according to cellular functions based upon distinct peptides quantitated at $95% confidence and having $2 peptides.
doi:10.1371/journal.pone.0026660.g003
Figure 4. Transmission Electron Microscopic (TEM) images of the A. Wild Type (WT) promastigotes and B. Paromomycin resistant
promastigotes. WT promastigotes were harvested and fixed as mentioned in Materials and methods and subjected to TEM analysis. PRr strain
displayed numerous vacuoles compared to the wild type strain. Images are representative of 2 independent experiments. FP: Flagellar Pocket; V:
Vacuole; N: Nucleus; K: Kinetoplast.
doi:10.1371/journal.pone.0026660.g004
Mode of Action of Paromomycin in L. donovani
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26660
Proteins Involved in DNA/RNA Processing
A few proteins involved in transcription were also identified
including some of the histones which are important for DNA
replication and nucleosome assembly. Basic transcription factor 3a
(BTF3a) putative was found to be,3 fold upregulated. It has been
observed that down-regulation of BTF3a is involved in inhibition
of transcription and proteins synthesis in the apoptotic K562 cells
[33]. It also acts as a transcriptional regulator and is associated
with apoptosis and/or cell cycle arrest [34,35]. Two of the nucleic
acid associated proteins involved in RNA processing were found to
be significantly down regulated in case of the PR resistant strain.
Fibrillarin, a key small nucleolar protein in eukaryotes which plays
an important role in ribosomal biogenesis was found to be ,2.2
fold downregulated in the PR resistant strain [36]. Fibrillarin
(NOP1) is highly conserved throughout evolution from unicellular
organisms such as yeast and trypanosomes to humans [37]. It is
involved in rRNA processing and modification in Trypanosoma
brucei [38]. A NOP1 knockout is lethal in S. cerevisiae and mutants of
this gene exhibit defects in pre-rRNA processing, modification and
ribosome assembly [39].
Drug Affinity Pull Down-Assay of the Paromomycin
Interacting Proteins
The combination of drug affinity pull-down assays with in situ
digestion and LC-MS/MS analysis is a useful tool in obtaining
complex information about a primary drug target as well as its
protein interactors. Pull down-assay using the PR linked resin
followed by LC-MS/MS analysis revealed a number of proteins
upon LC-MS/MS analysis which might be interacting with PR
inside the cell. The basic scheme of the experiment is shown in
Figure 5.The data obtained for PR linked and unlinked resins were
compared to obtain the proteins that bound exclusively to the PR
linked resin. The identified proteins that interacted with PR are
listed in Table 3. Of particular interest were the paraflagellar rod
proteins 1D and 2C, found only in the flagellum of the parasites
[40]. Another protein, prohibitin was also found to interact with
PR. Prohibitin in Leishmania is reported to be concentrated at the
surface of the flagellar and the aflagellar pole [28]. The flagellar
pocket membrane is the only part of the cell surface that supports
endocytosis and exocytosis [41]. The present data further supports
the role of such a process in drug uptake. Another protein, P-type
H+ ATPase putative was also found to be interacting with PR.
This protein is reported to be localized in the intracellular
compartments and is involved in the acidification and forms a part
of endocytic pathway in Trypanosoma cruzi [42]. It is possible that
the PR interacts with this protein after it is endocytosed or
sequestered in the vesicles by the parasite.
Discussion
The control of leishmaniasis relies mainly on a few chemother-
apeutic agents and emerging resistance towards these agents is one
of the major clinical problems today. Paromomycin, an amino-
glycoside antibiotic, is one of the drugs currently used in the
chemotherapy of cutaneous and visceral leishmaniasis. Paromo-
mycin inhibits protein synthesis by interacting with ribosomal
RNA subunits [1]. However, its mode of action is not well
understood in Leishmania spp. Reports suggest that paromomycin
might act by interacting with the ribosomes or disrupting the
mitochondrial membrane potential [14,15]. In order to under-
stand the mode of action of this antibiotic at the molecular level,
we employed a quantitative proteomics technique using stable
isotope labeling with amino acids in cell culture (SILAC) coupled
with mass spectrometry to quantify changes in protein levels
between paromomycin resistant (PRr) and sensitive cells.
We had earlier elucidated the effect and mechanism of uptake of
paromomycin in Leishmania donovani [15]. Our earlier work suggests
binding of the cationic paromomycin to the negatively charged
leishmanial glycocalyx. In bacteria, aminoglycosides are reported
to associate with lipopolysaccharide (LPS) and other anionic
components of the bacterial cell surface [43]. Lipophosphoglycan
(LPG), a highly negatively charged molecule is a major component
of the cell surface of promastigotes of Leishmania [44,45]. Several
glycosylphosphatidylinositols have been reported to accumulate in
the endosomes [46,47]. We had earlier proposed that paromo-
mycin associates with LPG at the leishmanial surface and also
suggested other components may also be involved in binding. Our
hypothesis was that after binding to the surface, internalization
appears to proceed by endocytosis since a number of typical
inhibitors of endocytosis reduced the rate of uptake of the drug
[15]. Once inside the cell it is possible that the drug enters the
mitochondrion. The uptake of this cationic agent in the
mitochondria is dependent on the high membrane potential [15].
The present study was aimed to investigate the global proteome
differences between the wild type AG83 strain and a paromomy-
cin resistant (PRr) strain of L. donovani. Table 4 gives a brief
summary of the classes of proteins that were altered in the PR
resistant strain. The identified parasite proteins further support our
earlier understanding of the mode of action and underlying
mechanism of resistance to paromomycin in Leishmania. Proteome
screens have been shown to be useful for identifying novel
resistance mechanisms. The data revealed changes in the level of
proteins involved in metabolic processes like glycolysis and those
involved in other fundamental processes like translation, tran-
scription, signal transduction, chaperones/stress, intracellular
survival and pro-apoptosis.
Several of the proteins involved in the translational machinery,
especially the ribosomal proteins, were found to be upregulated in
the resistant strain (Table 1). In Leishmania, paromomycin has been
implicated in targeting ribosomes directly and differential effects of
paromomycin on the translation processes of the Leishmania
parasite and its mammalian hosts has also been reported [48].
In light of this, our data on the up-regulation of the ribosomal
proteins could be explained as one of the mechanisms utilized by
the resistant parasites as a defence against paromomycin.
Furthermore, our previous report also shows an overall less
percent inhibition of protein synthesis by paromomycin in the PRr
strain as compared to the WT [15].
Of the upregulated proteins in the PRr strain, LPG putative
deserves special attention as it has been identified as a virulence
factor in Leishmania [49]. Lipophosphoglycan biosynthetic protein,
putative or LPG3 is an ortholog of eukaryotic glucose regulated
protein 94 (GRP 94). Its null mutants in Leishmania are viable but
show severe defects in phosphoglycosylation. Its role has been
found to be restricted to the synthesis of glycoconjugates
implicated in parasite virulence, including LPG and other PG-
bearing molecules and GPI-anchored proteins [49].
LPG biosynthetic protein, vesicle fusing ATPase and vacuolar
ATPase were upregulated in the PR resistant strain. The ultra-
structural studies of the paromomycin resistant strain revealed the
presence of increased number of vesicular vacuoles in comparison
to the sensitive wild type strain (Figure 4).
Affinity pull-down assay using PR linked resin identified
proteins that interact with PR. Paraflagellar rod proteins and
prohibitin were found to interact with paromomycin. Prohibitin in
Leishmania is also reported to be concentrated at the surface of the
flagellar and the aflagellar pole [28]. It is well known that the
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flagellar pocket facilitates internalization of the molecules. Hence
binding of PR to the paraflagellar rod proteins and prohibitin is of
significance in the present study.
In summary, it is clear that the molecular mechanisms
contributing to paromomycin resistance comprise a complex
multifactorial network. In view of our earlier and present studies
we propose the following mode of action for PR in L. donovani
(Figure 6). It is proposed that the drug binds to the paraflagellar
rod proteins and prohibitin and then internalization appears to
proceed by endocytosis since a number of typical inhibitors of
endocytosis reduced the rate of uptake of the drug [15]. Another
protein, P-type H+ ATPase putative was also found to interact with
Table 3. Drug affinity pull-down assays with in situ digestion and LC-MS/MS analysis identified proteins from wild type L. donovani
promastigotes that bind to paromomycin.
S. No. Accession No. Name of Protein
Number of
Peptides Probability Percent coverage
1. LinJ16_V31510, LinJ16_V31520 Paraflagellar rod protein 2C 2 1 4.3
2. LinJ18_V3.1490, LinJ18_V3.1500,
LinJ18_V3.1510
P-type H+-ATPase, putative 3 0.99 5.8
3. LinJ29_V3.1880,
LinJ29_V3.1890
Paraflagellar rod protein 1D 5 1 9.3
4. LinJ31_V3.2680 RNA Polymerase II largest subunit 1 0.99 1.1
5. LinJ35_V3.0070 Prohibitin 1 0.95 4.8
The protein coverage is based on the non-redundant peptides identified by PeptideProphet.
The results are representative of two independent experiments.
doi:10.1371/journal.pone.0026660.t003
Figure 5. Overview of the affinity pull-down assay using PR-linked resin. Paromomycin was bound to AminoLink Plus coupling resin. The
PR-linked resin (experimental) and unlinked resin (used as negative control) were incubated with AG83 whole cell lysate. The beads were then
washed and the resin was loaded onto 10% SDS-PAGE gel. The gel was stained with sypro ruby and the fragments were excised and digested with
trypsin. The protein samples were analyzed by LC-MS/MS and the results compared to determine the proteins that interacted with PR selectively.
doi:10.1371/journal.pone.0026660.g005
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PR. This protein is localized in the intracellular compartments and
is reported to be involved in acidification and forms a part of
endocytic pathway in Trypanosoma cruzi [42]. It is possible that PR
interacts with this protein after it is endocytosed or sequestered in
the vesicles by the parasite. The vesicular sequestration of
paromomycin into the internal vesicles by the parasite using
Table 4. Modulation in expression of proteins in paromomycin -susceptible (AG83 WT) and -resistant (PRr) Leishmania donovani.
Cellular Function Proteins modulated in the Paromomycin resistant strain
Intracellular Survival, Processing and Virulence 14-3-3 protein, LPG biosynthetic protein and IgE dependent histamine release factor were found to be
upregulated. Prohibitin was found to be downregulated.
Vesicle trafficking Proteins involved in vesicle trafficking, fusion and endocytosis like vesicle fusing ATPase and vacuolar ATP
synthase were found to be upregulated.
Translation Ribosomal proteins were found to be upregulated in the PR resistant strain. This may be because PR is known
to inhibit translation in E. coli
Chaperones/stress proteins Heat shock proteins and chaperonins were found to be upregulated. HSPs protect cell from toxic external
stimuli and have been implicated in drug resistance.
Metabolism Proteins involved in glycolysis were seen to be upregulated
doi:10.1371/journal.pone.0026660.t004
Figure 6. Proposed model for mechanism of paromomycin resistance in L. donovani. (I) The drug paromomycin (red circles) interacts with
paraflagellar rod proteins (blue circles) and prefoldin (yellow circles) and is then taken up by the Leishmania promastigotes by endocytosis. PR is then
sequestered in to the vacuoles. The pump, vacuolar ATPase is found to be upregulated and the number of vacuoles is increased in the resistant parasites. (II)
The chaperone proteins are found to be upregulated in the resistant cells as a result of the stress caused by paromomycin and are also involved in increased
protein turnover. (III) A number of ribosomal protein subunits were found to be regulated, increasing the total protein synthesis. (IV) The glycolytic pathway
was found to be upregulated. Proteins marked in red represent the upregulated proteins and the ones marked in green represent the down- regulated
proteins in the case of paromomycin resistant strain. Enzymes indicated: (1) Hexokinase, (2) Phosphoglucose isomerase, (3) Phosphofructokinase, (4)
Aldolase (5) Triose phosphate isomerase, (6) Glyceraldehyde 3-phosphate dehydrogenase, (7) Phosphoglycerate kinase (8) 2,3-bisphosphoglycerate
independent phosphoglycerate mutase, (9) Enolase, (10) Pyruvate kinase, (11) Malic enzyme (12) glucose 6-phosphate dehydrogenase.
doi:10.1371/journal.pone.0026660.g006
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fluorescent derivative of the aminoglycoside antibiotic, paromo-
mycin would be required to show that the drug accumulates in the
vesicles. It is possible that vesicular sequestration of paromomycin
in to the vacuoles by these resistant parasites might be involved in
conferring the resistance phenotype. Once inside the cell PR
inhibits protein synthesis by targeting several of the proteins
involved in the translational machinery, in particular the
ribosomal proteins. Overall, this study characterized the mode of
action and underlying mechanism of resistance to paromomycin in
Leishmania donovani. However, further investigation of vesicle-
mediated mechanism of paromomycin resistance is presently
going on in the laboratory to conclusively show drug sequestration
into the internal vesicles of the resistant parasites.
Materials and Methods
Chemicals
The medium M199 deficient in L-lysine and L-arginine was
custom synthesized from SAFC biosciences (MO, USA). The
labeled amino acids, 13C6 L-lysine-HCl and
13C6
15N4 L-arginine-
HCl were obtained from Pierce Biotech (Illinois, USA). Dialyzed
fetal bovine serum was purchased from Invitrogen (CA, USA).
Mass spec (MS) grade trypsin was purchased from Promega (WI,
USA). AminoLink coupling resin was purchased from Pierce
Biotech (IL, USA). All the solvents used for preparation and
running of samples were of MS grade and were available
commercially.
Parasite and Culture Conditions
Promastigotes of Leishmania donovani clones, AG83 (MHOM/
IN/80/AG83) wild-type (WT) and a paromomycin resistant strain
(PRr) were used in the present study. PRr strain used in this study
was raised in the laboratory as reported [15]. PRr strain had an
IC50 of 145 mM and was three-fold resistant to paromomycin
compared to the wild-type [15]. Promastigotes were routinely
cultured at 22uC in modified M-199 medium (Sigma, St. Louis.
MO, USA) supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Gibco/BRL, Life Technologies Scotland, UK) and
0.13 mg/mL penicillin and streptomycin.
SILAC Labeling of Cells
For SILAC analysis, promastigotes were grown in custom
synthesized media, M199 depleted of L-lysine and L-arginine
(Sigma, USA) supplemented with 10% dialyzed fetal bovine serum
(Invitrogen, Carlsbad, CA, USA), antibiotics and one of the two
SILAC media formulations at 22uC [normal isotopic abundance
L-lysine (70 mg/L) and L-arginine (70 mg/L)] for the wild type
and 13C6 L-lysine-HCl and
13C6
15N4 L-arginine-HCl (Pierce
Biotechnology) for the PRr parasites] (Fig. 1). A regular sub-
culturing in this medium was done for at least six cell divisions in
order to achieve 100% labeling of the cellular proteins before
analysis.
Preparation of Protein Samples
The cells were harvested, washed with 1X PBS and lysed. The
protein was quantitated by Bradford’s method [50] and equal
amount of protein (100 mg) from both the cell lysates was mixed
and separated by 10% SDS-PAGE and stained with Sypro Ruby
stain (Bio-Rad). The entire gel lane was cut into 10 sections for in-
gel digestion. Each section was further cut into small pieces of
approximately 1 mm each. The gel pieces were dehydrated in the
presence of 50% acetonitrile and then rehydrated with 50 mM
ammonium bicarbonate. Digestion of the samples was carried out
using sequencing grade modified trypsin (Promega) (12.5 ng/ml) in
50 mM ammonium bicarbonate at 37uC overnight. The tubes
were then centrifuged and supernatant collected. The peptides
were extracted from the gel using 20 mM ammonium bicarbon-
ate, followed by extraction with 5% formic acid in 50%
acetonitrile. The samples were dried in speedvac and stored at
280uC till further analysis.
Liquid Chromatography–Mass Spectrometry (LC-MS/MS),
Data Base Analysis and Relative Quantification
LC-MS/MS was performed using LTQ linear ion trap mass
spectrometer (Thermo Fisher Scientific). The LC system consisted
of a fused-silica nanospray needle packed in-house with C18
reverse-phase material. The peptide samples were loaded onto the
reversed phase column using a two-mobile-phase solvent system
consisting of 0.4% acetic acid in water (A) and 0.4% acetic acid in
acetonitrile (B) at a flow rate of 200 ml/min. The mass
spectrometer operated in a data-dependent MS/MS mode over
the m/z range of 400–2000. For each cycle, the five most
abundant ions from each MS scan were selected for MS/MS
analysis using 45% normalized collision energy. Dynamic
exclusion was used to exclude ions that had been detected twice
in a 30 sec window for 3 min. Raw MS/MS data were submitted
to Bioworks 3.3 (ThermoElectron, San Jose, CA, USA) and
searched using the SEQUEST algorithm against L. infantum
protein database ver 3.0 (ftp://ftp.sanger.ac.uk/pub/pathogens/
L_infantum/). The SEQUEST output files were analyzed and
validated by PeptideProphet. Proteins and peptides with a
probability score of $0.9 were accepted. The quantification was
based on two independent SILAC and LC-MS/MS experiments.
Transmission Electron Microscopy
Cells were fixed in a solution of 2% paraformaldehyde and
2.5 mM CaCl2 in 0.1 M sodium cacodylate buffer pH 7.2, post-
fixed in 1% osmium tetroxide and 0.8% potassium ferricyanide in
the same buffer, dehydrated in an acetone series and embedded in
Polybed resin. Thin sections were stained with uranyl acetate and
lead citrate and observed under a FEI MorgagniTM transmission
electron microscope. Images are representative of 2 independent
experiments.
Affinity Pull-Down of the Paromomycin Interacting
Proteins
Paromomycin (PR) was linked to AminoLink plus coupling resin
(Pierce Biotechnology) according to the manufacturer’s protocol
(the resin contains aldehyde groups that react with primary amines
present in paromomycin to form Schiff’s base bonds). The
unbound paromomycin was removed by centrifuging the resin at
2000 rpm and then washing with 1 X phosphate buffered saline
(PBS), pH 7.2. The binding efficiency of the beads with PR was
found to be 66%. Wild-type AG83 cells (16108) were harvested
and lysed with lysis buffer (10 mM Tris.Cl pH 7.2, 10 mM
MgCl2, 150 mM KCl, 0.1% Triton-X 100, 1% BSA and protease
inhibitor cocktail). The lysate was incubated with paromomycin-
linked agarose beads for 2 h at 4uC with continuous mixing. The
suspension was then centrifuged at 2000 rpm for 10 min at 4uC
and the beads were transferred to a fresh tube. The beads were
washed four times with a wash buffer (10 mM Tris.Cl pH 7.2,
10 mMMgCl2, 150 mM KCl and 0.1% Triton-X 100) and finally
resuspended in 1X SDS PAGE dye and loaded onto 10% SDS-
PAGE gel. The gel was stained with Sypro Ruby stain and the
bands were visualized under UV and desired bands were cut and
subjected to the LC-MS/MS analysis in a 4000 Q TRAP LC-MS/
MS system (Applied Bisosytems MDS SCIEX) for peptide
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ionization and detection. The SEQUEST output files were
analyzed and validated by PeptideProphet. Proteins and peptides
with a probability score of $0.9 were accepted. Beads not linked
with paromomycin were used as negative control. The results are
representative of two independent experiments.
Supporting Information
Table S1 List of proteins identified in Set A and Set B at
$95% confidence.
(XLS)
Table S2 Proteins identified using SILAC and catego-
rized on the basis of function quantitated at .95%
confidence and having $2 peptides.
(XLS)
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